Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Lewitzky

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Opinion in Biotechnology|November 21, 2007
Reprogramming somatic cells towards pluripotency by defined factorsMarc Lewitzky, Shinya Yamanaka
Cell Communication and Signaling : CCS|June 16, 2012
Very 'sticky' proteins - not too sticky after all?Stephan M Feller, Marc Lewitzky
Current Pharmaceutical Design|February 14, 2006
Potential disease targets for drugs that disrupt protein-- protein interactions of Grb2 and Crk family adaptorsStephan M Feller, Marc Lewitzky
Cell Communication and Signaling : CCS|September 29, 2016
Hunting for the ultimate liquid cancer biopsy - let the TEP dance beginStephan M Feller, Marc Lewitzky
Cell Communication and Signaling : CCS|November 1, 2012
What's in a loop?Stephan M Feller, Marc Lewitzky
FEBS Letters|June 20, 2012
Beyond 'furballs' and 'dumpling soups' - towards a molecular architecture of signaling complexes and networksMarc Lewitzky, Philip C Simister, Stephan M Feller
Mechanisms of Development|July 20, 2002
SH3 domain-mediated binding of the Drk protein to Dos is an important step in signaling of Drosophila receptor tyrosine kinasesStephan M Feller, Heike Wecklein, Marc Lewitzky, et al.
The Journal of Biological Chemistry|April 22, 2004
Mona/Gads SH3C binding to hematopoietic progenitor kinase 1 (HPK1) combines an atypical SH3 binding motif, R/KXXK, with a classical PXXP motif embedded in a polyproline type II (PPII) helixMarc Lewitzky, Maria Harkiolaki, Marie-Charlotte Domart, et al.
Cell Communication and Signaling : CCS|June 19, 2025
The Src family kinase inhibitor drug Dasatinib and glucocorticoids display synergistic activity against tongue squamous cell carcinoma and reduce MET kinase activityAli N A Hmedat, Jessica Doondeea, Daniel Ebner, et al.
Journal of Molecular Biology|December 20, 2021
Macromolecular Crowding Induces a Binding Competent Transient Structure in Intrinsically Disordered Gab1Tobias Gruber, Marc Lewitzky, Lisa Machner, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Opinion in Biotechnology|November 21, 2007
Reprogramming somatic cells towards pluripotency by defined factorsMarc Lewitzky, Shinya Yamanaka
Cell Communication and Signaling : CCS|June 16, 2012
Very 'sticky' proteins - not too sticky after all?Stephan M Feller, Marc Lewitzky
Current Pharmaceutical Design|February 14, 2006
Potential disease targets for drugs that disrupt protein-- protein interactions of Grb2 and Crk family adaptorsStephan M Feller, Marc Lewitzky
Cell Communication and Signaling : CCS|September 29, 2016
Hunting for the ultimate liquid cancer biopsy - let the TEP dance beginStephan M Feller, Marc Lewitzky
Cell Communication and Signaling : CCS|November 1, 2012
What's in a loop?Stephan M Feller, Marc Lewitzky
FEBS Letters|June 20, 2012
Beyond 'furballs' and 'dumpling soups' - towards a molecular architecture of signaling complexes and networksMarc Lewitzky, Philip C Simister, Stephan M Feller
Mechanisms of Development|July 20, 2002
SH3 domain-mediated binding of the Drk protein to Dos is an important step in signaling of Drosophila receptor tyrosine kinasesStephan M Feller, Heike Wecklein, Marc Lewitzky, et al.
The Journal of Biological Chemistry|April 22, 2004
Mona/Gads SH3C binding to hematopoietic progenitor kinase 1 (HPK1) combines an atypical SH3 binding motif, R/KXXK, with a classical PXXP motif embedded in a polyproline type II (PPII) helixMarc Lewitzky, Maria Harkiolaki, Marie-Charlotte Domart, et al.
Cell Communication and Signaling : CCS|June 19, 2025
The Src family kinase inhibitor drug Dasatinib and glucocorticoids display synergistic activity against tongue squamous cell carcinoma and reduce MET kinase activityAli N A Hmedat, Jessica Doondeea, Daniel Ebner, et al.
Journal of Molecular Biology|December 20, 2021
Macromolecular Crowding Induces a Binding Competent Transient Structure in Intrinsically Disordered Gab1Tobias Gruber, Marc Lewitzky, Lisa Machner, et al.
Pageof 2